Cargando…

EXD2 Protects Stressed Replication Forks and Is Required for Cell Viability in the Absence of BRCA1/2

Accurate DNA replication is essential to preserve genomic integrity and prevent chromosomal instability-associated diseases including cancer. Key to this process is the cells’ ability to stabilize and restart stalled replication forks. Here, we show that the EXD2 nuclease is essential to this proces...

Descripción completa

Detalles Bibliográficos
Autores principales: Nieminuszczy, Jadwiga, Broderick, Ronan, Bellani, Marina A., Smethurst, Elizabeth, Schwab, Rebekka A., Cherdyntseva, Veronica, Evmorfopoulou, Theodora, Lin, Yea-Lih, Minczuk, Michal, Pasero, Philippe, Gagos, Sarantis, Seidman, Michael M., Niedzwiedz, Wojciech
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cell Press 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6695479/
https://www.ncbi.nlm.nih.gov/pubmed/31255466
http://dx.doi.org/10.1016/j.molcel.2019.05.026
Descripción
Sumario:Accurate DNA replication is essential to preserve genomic integrity and prevent chromosomal instability-associated diseases including cancer. Key to this process is the cells’ ability to stabilize and restart stalled replication forks. Here, we show that the EXD2 nuclease is essential to this process. EXD2 recruitment to stressed forks suppresses their degradation by restraining excessive fork regression. Accordingly, EXD2 deficiency leads to fork collapse, hypersensitivity to replication inhibitors, and genomic instability. Impeding fork regression by inactivation of SMARCAL1 or removal of RECQ1’s inhibition in EXD2(−/−) cells restores efficient fork restart and genome stability. Moreover, purified EXD2 efficiently processes substrates mimicking regressed forks. Thus, this work identifies a mechanism underpinned by EXD2’s nuclease activity, by which cells balance fork regression with fork restoration to maintain genome stability. Interestingly, from a clinical perspective, we discover that EXD2’s depletion is synthetic lethal with mutations in BRCA1/2, implying a non-redundant role in replication fork protection.